Free shipping! Love it or your money back.

Peter Lio, MD, Gladskin advisor

Board-Certified Dermatologist
Scientific Advisory Board for
National Eczema Association

Skin Microbiome: The key to treating eczema flares

While the role of the Staphylococcus aureus in eczema flares is well understood in the medical community, there have never been options to target it long term without resistance while sparing the commensal bacteria.

Eczema flare severity is correlated with high Staphyloccous colonization and low microbial diversity
(Kong et al, Genome Res. 2012)

Time (Atopic Dermatitis disease progression)

Benefits of Gladskin with Micreobalance™ Endolysin


Balances the skin microbiome.


Preserves the protective commensal bacteria, including s. epidermidis.


Strengthens the skin barrier.

Hear from our Scientific Advisory Board

Play Video

Peter Lio, MD

Board-Certified Dermatologist; Assistant Clinical Professor of Dermatology & Pediatrics, Northwestern University School of Medicine; Scientific Advisory Board for National Eczema Association

Play Video

Richard Antaya, MD

Professor, Department of Pediatrics University of Washington School of Medicine; Chief, Division of Dermatology, Seattle Children's Hospital

Patient use study results

German Eczema Patient Society study of self reported outcomes after using Gladskin (European formula) demonstrated 76% of people experienced improvement within a few days.

Speed and degree of response to Gladskin among total subjects

Speed and degree of response to Gladskin among responders

Gladskin has a robust safety profile 

  • Gladskin has been on the market in Europe since 2016 without concerning adverse event reports
  • Now Gladskin Eczema Cream is manufactured in a cGMP FDA registered manufacturing facility in the U.S.*
  • Safety demonstrated in a 100 patient placebo controlled trial
  • Passed 21 Day Cumulative Irritation Test
  • Passed HRIPT Testing on sensitive skin panel
  • Passed phototoxicity panel test
  • *Gladskin Eczema Cream available in the U.S. is the same formulation as the product available in Europe with the addition of 0.02% USP colloidal oatmeal.

Gladskin has been used safely throughout Europe since 2016

Instructions for patient and caretaker use

  • Gladskin with Micreobalance™ is approved for use without prescription by adults and children 3 months and up
  • Use Gladskin twice a day, or more as desired, on skin free of other products
  • Wait at least 10 minutes after applying Gladskin before applying other topical products
  • Can be used alongside corticosteroids